This metabolite incorporates a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 around 50% of the guardian drug. Plasma concentrations of this metabolite are approximately forty% of People observed for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharmacologic consequences.Sildenafil can re